Summary List Placement
The AstraZeneca coronavirus vaccine should not be given to people under the age of 30, UK regulators said Wednesday.
The Guardian reported that the UK’s Joint Committee on Vaccines and Immunisation (JCVI) recommended offering under-30s another vaccine instead.
Most people of that age have not yet been offered vaccines in the UK, which has concentrated on older demographics first.
The reason for the change is a small number of blood clots in people given the vaccine. Officials at the briefing described them as a “suspected” side-effect of the shot, and said that it was very rare.
At the briefing Wednesday, Jonathan Van-Tam described the change as a “course correction” and said that the vaccine rollout had overall been a success.
Dr June Raine, Chief Executive of Medicines and Healthcare products Regulatory Agency (MHRA) said of the blood clots that “the risk of this rare of this rare suspected side effect remains extremely small.”
The risk benefit balance remains favourable for most, but are “more finely balanced” in younger age groups, Sir Munir Pirmohamed, Chair of the Committee of Human Medicines, said.
Similar reports prompted earlier suspensions of the AstraZeneca rollout in many countries, some of which later restricted the use of the shot in younger demographics.